{
    "title": "Single patient study adds to debate over Gilead's remdesivir for COVID-19",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9050855/Single-patient-study-adds-debate-Gileads-remdesivir-COVID-19.html",
    "date": "2020-12-14",
    "keywords": [
        "remdesivir",
        "covid19",
        "drug",
        "treatment",
        "study",
        "disease",
        "virus",
        "condition",
        "effectiveness",
        "infection",
        "course",
        "kate",
        "kelland",
        "coronavirus",
        "matheson",
        "immunology",
        "case",
        "man",
        "singlepatient",
        "impact",
        "death",
        "nature",
        "patient",
        "disorder",
        "improvement",
        "disappearance",
        "insight",
        "cambridge",
        "institute",
        "response",
        "challenge",
        "hepatitis",
        "c",
        "ebola",
        "world",
        "health",
        "trial",
        "october",
        "survival",
        "editorial",
        "england",
        "journal",
        "medicine",
        "month",
        "solidarity",
        "wave",
        "team",
        "xla",
        "bodys",
        "ability",
        "period",
        "hydroxychloroquine",
        "azithromycin",
        "effect",
        "day",
        "buckland",
        "doctor",
        "department",
        "reporting",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}